Osteogenic Growth Peptide, OGP is a short, naturally occurring 14-mer growth factor peptide found in serum at μM concentrations.
CAT No: R1579
CAS No:132996-61-3
Synonyms/Alias:Osteogenic growth peptide;132996-61-3;DTXSID30157894;Glycine, L-alanyl-L-leucyl-L-lysyl-L-arginyl-L-glutaminylglycyl-L-arginyl-L-threonyl-L-leucyl-L-tyrosylglycyl-L-phenylalanylglycyl-;CHEMBL3585474;DTXCID4080385;DA-76477;PD159392;G12503;
Osteogenic Growth Peptide, OGP, is a naturally occurring peptide fragment recognized for its pivotal role in skeletal biology and bone tissue modulation. Structurally derived from the C-terminal region of histone H4, OGP is distinguished by its capacity to influence osteoblast proliferation and differentiation, making it a focal point in bone metabolism research. Its unique sequence and bioactivity have positioned it as a valuable molecular tool for exploring the regulatory mechanisms underlying bone formation and remodeling. As a synthetic research peptide, OGP is widely utilized in cellular and molecular studies that seek to elucidate the pathways governing osteogenesis and skeletal repair.
Bone Cell Biology Research: OGP is extensively employed in studies investigating the proliferation and differentiation of osteoblasts, the primary bone-forming cells. By providing a defined biochemical stimulus, it enables researchers to dissect the signaling pathways and gene expression profiles involved in osteogenic commitment. These studies contribute to a deeper understanding of bone tissue development, maintenance, and the molecular basis of bone-related disorders. The peptide's capacity to selectively stimulate osteoblast activity makes it a preferred reagent in in vitro models designed to mimic bone formation and turnover.
Peptide Receptor Interaction Studies: The ability of OGP to engage specific cell surface receptors on osteogenic cells is a subject of ongoing investigation. Researchers leverage its defined structure to probe receptor-ligand interactions, downstream signaling cascades, and the modulation of cellular responses. Such studies are instrumental in mapping the molecular targets of osteogenic peptides and in characterizing the cross-talk between peptide signals and other growth factors. These insights are critical for advancing the fundamental understanding of bone biology and for identifying potential modulators of skeletal cell function.
Tissue Engineering and Biomaterials Research: OGP is frequently incorporated into biomaterial scaffolds and engineered matrices to assess its effects on cellular attachment, proliferation, and matrix mineralization. By integrating the peptide into synthetic or natural substrates, scientists can evaluate its potential to enhance the osteoinductive properties of biomaterials. This application supports the development of advanced scaffolding systems for bone tissue engineering, where controlled peptide delivery and localized bioactivity are essential for promoting functional tissue regeneration in experimental models.
Peptide Synthesis and Analogue Development: The well-characterized sequence of OGP serves as a template for the design and synthesis of structural analogues and peptide mimetics. Research groups utilize the native peptide as a benchmark for evaluating the activity of novel derivatives, with the aim of optimizing stability, receptor affinity, or biological potency. This approach facilitates the rational development of next-generation osteogenic peptides for use in experimental protocols and materials science, expanding the toolkit available for bone biology research.
Analytical and Quantitative Assays: OGP is also applied as a standard or control in a variety of analytical techniques, including immunoassays, mass spectrometry, and chromatography-based methods. Its defined molecular properties make it suitable for calibrating detection systems, validating assay performance, and quantifying peptide concentrations in complex biological samples. These analytical applications are essential for ensuring the reliability and reproducibility of peptide-based measurements in bone research and related biochemical investigations.
2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
3. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More